Jonathan E. Lim - Dec 31, 2022 Form 5 Insider Report for Erasca, Inc. (ERAS)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
/s/ Ebun Garner, Attorney-in-Fact
Stock symbol
ERAS
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
2/15/2023, 07:55 PM
Previous filing
Dec 15, 2022
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERAS Common Stock Gift $0 -2M -9.9% $0.00 18.2M Nov 30, 2022 Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005 F1, F2
holding ERAS Common Stock 11.9M Dec 31, 2022 City Hill, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer of shares to a trust of which the children of the Reporting Person and his spouse are beneficiaries.
F2 The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F3 Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.